# L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer

> **NCT00754767** · PHASE4 · TERMINATED · sponsor: **HealthPartners Institute** · enrollment: 2 (actual)

## Conditions studied

- Breast Cancer
- Chemotherapeutic Agent Toxicity
- Neurotoxicity

## Interventions

- **DRUG:** L-carnitine L-tartrate
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00754767
- **Lead sponsor:** HealthPartners Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-01-02
- **Primary completion:** 2008-04-02
- **Final completion:** 2008-05-02
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** unable to accrue study participants
- **Last updated:** 2017-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00754767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00754767, "L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00754767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*